Clinical Trials Browser

Withdrawn × Carcinoma, Hepatocellular × Biopsy × Clear all

NCT05327738 2022-12-14

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular